EcoDrugPlus

Ribosomal Protein L14

Ensembl ID : ENSPSNG00000011475
Gene Symbol: RPL14
3 Cross references
251 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSPSNG00000017926
Gene Symbol: RPL18
2 Cross references
318 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSPSNG00000003841
Gene Symbol: RPL18A
3 Cross references
166 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSPSNG00000020768
Gene Symbol: RPL19
3 Cross references
241 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSPSNG00000003761
Gene Symbol: RPL22
3 Cross references
36 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSPSNG00000002246
Gene Symbol: RPL24
3 Cross references
302 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSPSNG00000021919
Gene Symbol: RPL26
1 Cross references
196 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSPSNG00000007010
Gene Symbol: RPL29
2 Cross references
320 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSPSNG00000009490
Gene Symbol: RPL3
2 Cross references
271 Possible Orthologues:

Ribosomal Protein L32

Ensembl ID : ENSPSNG00000022724
Gene Symbol: RPL32
3 Cross references
135 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSPSNG00000015051
Gene Symbol: RPL35
3 Cross references
247 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSPSNG00000021056
Gene Symbol: RPL35A
3 Cross references
116 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).